News FocusProfile: Bert Vogelstein

Cancer Genetics With an Edge

Science  20 Jul 2012:
Vol. 337, Issue 6092, pp. 282-284
DOI: 10.1126/science.337.6092.282

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Bert Vogelstein and Kenneth Kinzler, who co-direct a lab at the Johns Hopkins University medical campus, helped lay the foundation of cancer genetics by revealing how mutations in key genes lead to a tumor. Their work helped inspire others to use genetics to predict cancer risks and develop personalized cancer treatments. Yet today, Vogelstein often offers what he calls a "reality check" on such efforts. In the past few years, Vogelstein and Kinzler have shifted away from discovering new cancer genes to a less glamorous pursuit: using genetic tests to detect common tumors as early as possible, when they are easiest to cure. This is not mainstream work, they say. But it's a natural progression of earlier research, the two said in a recent interview. Their research was never driven by curiosity about biology, Vogelstein says, but by "an overwhelming desire to empty the cancer clinics across the street."